Elderly Acute Myeloid Leukemia: Assessing Risk-Reference-Cited by-同舟云学术

Elderly Acute Myeloid Leukemia: Assessing Risk

Published:2015-05-05 Issue:2 Volume:10 Page:118-125
ISSN:1558-8211
Container-title:Current Hematologic Malignancy Reports
language:en
Short-container-title:Curr Hematol Malig Rep

Author:

Klepin Heidi D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11899-015-0257-2.pdf

Reference54 articles.

1. SEER Cancer Statistics Review 1975–2009. http://seer.cancer.gov/publications/ [Internet]. 2012. Available from: http://seer.cancer.gov/publications/ .

2. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481–5.

3. Kantarjian H, O’brien S, Cortes J, Giles F, Faderl S, Jabbour E, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. 2006;106(5):1090–8.

4. Lowenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol. 1989;7(9):1268–74.

5. Juliusson G. Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment. Blood. 2011;117(12):3473–4.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy;JAMA Oncology;2024-08-01

2. Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine;Hematology;2024-03-03

3. Synergy and antagonism between azacitidine and FLT3 inhibitors;Computers in Biology and Medicine;2024-02

4. The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine;The Korean Journal of Internal Medicine;2023-07-01

5. Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience;Journal of Chemotherapy;2022-07-26